SOFAB LP LEDIPASVIR AND SOFOSBUVIR TABLETS

Get a Price/Quote

SOFAB LP LEDIPASVIR AND SOFOSBUVIR TABLETS Specification

Indication
Treatment of chronic hepatitis C genotype 1, 4, 5, 6 infection

Origin of Medicine
India

Salt Composition
Ledipasvir 90 mg and Sofosbuvir 400 mg

Dosage Form
Oral tablets

Pacakaging (Quantity Per Box)
28 tablets

Drug Type
Allopathic

Ingredients
Ledipasvir 90 mg, Sofosbuvir 400 mg

Physical Form
Tablets

Function
Antiviral medication

Recommended For
Chronic Hepatitis C Virus (HCV) infection

Dosage
As directed by physician

Dosage Guidelines
One tablet once daily

Suitable For
Adults

Quantity
28 tablets per box

Storage Instructions
Store below 30C, protect from light and moisture

SOFAB LP LEDIPASVIR AND SOFOSBUVIR TABLETS Trade Information

Packaging Details
PACK OF 28 TABLETS

Main Domestic Market
All India

About SOFAB LP LEDIPASVIR AND SOFOSBUVIR TABLETS

Sofab Lp

Specifications :-

Strength:90 mg +400 mg
Form:Tablet
Manufacturer:Ranbaxy
Packaging Size:pack of 28 tablets
Composition:Ledipasvir & Sofosbuvir

Note :- SOFAB LP Is A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice. Do Not Share The Medicine With Others, Since They May Be Suffering From A Problem That Is Not Effectively Treated By This Drug............

Effective Hepatitis C Treatment

SOFAB LP is formulated to deliver targeted antiviral therapy for patients battling chronic Hepatitis C. Its dual-action formula, combining Ledipasvir and Sofosbuvir, disrupts viral replication, helping reduce the viral load and progression of the disease. Physicians widely recommend this therapy for adults diagnosed with specific HCV genotypes.

Convenient Dosing

This medications oral tablet form ensures ease of use, requiring only one tablet once daily as per physician direction. Each box contains a full 28-day supply, allowing for a seamless monthly treatment regimen. Its user-friendly packaging caters to the needs of both patients and healthcare providers.

Trusted Allopathic Formulation

Manufactured in India, SOFAB LP brings together high-quality pharmaceutical standards and efficacy. Its shelf life of 24 months guarantees lasting stability, while strict storage requirements preserve its effectiveness. It is distributed globally through reputable suppliers and exporters.

FAQs of SOFAB LP LEDIPASVIR AND SOFOSBUVIR TABLETS:

Q: How should SOFAB LP LEDIPASVIR AND SOFOSBUVIR TABLETS be taken for best results?

A: SOFAB LP should be taken orally, with one film-coated tablet once daily as prescribed by a physician. It is important to follow the recommended dosage schedule and not miss any doses to ensure optimal antiviral effects.

Q: What is the main therapeutic benefit of SOFAB LP?

A: SOFAB LP is designed to treat chronic Hepatitis C infection by inhibiting viral replication, thus reducing the viral load and helping prevent the progression of liver disease associated with HCV genotypes 1, 4, 5, and 6.

Q: When is it appropriate to use SOFAB LP LEDIPASVIR AND SOFOSBUVIR TABLETS?

A: This medication is recommended for adult patients diagnosed with chronic Hepatitis C Virus infection, specifically for genotypes 1, 4, 5, and 6, and should be initiated under the guidance of a healthcare professional.

Q: Where should SOFAB LP tablets be stored to maintain their quality?

A: SOFAB LP tablets should be stored below 30C in a dry place, protected from light and moisture. Proper storage ensures the integrity and effectiveness of the medication throughout its 24-month shelf life.

Q: What is the process for obtaining SOFAB LP tablets?

A: SOFAB LP is a prescription medication and must be obtained through a healthcare provider. Distributors, exporters, suppliers, traders, and wholesalers in India make it widely accessible for clinical use.

Q: Who is SOFAB LP suitable for?

A: SOFAB LP is suitable for adults diagnosed with chronic Hepatitis C Virus infection, following the doctors prescribed dosage and treatment duration.